Skip to main content
Clinical Trials/CTRI/2024/07/070009
CTRI/2024/07/070009
Recruiting
Phase 2

A randomised comparative study to evaluate the efficacy and safety of thirty percent metformin cream versus triple combination cream versus tranexamic acid cream in the treatment of melasma - Nil

Dr Namitha P0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: L811- Chloasma
Sponsor
Dr Namitha P
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Dr Namitha P

Eligibility Criteria

Inclusion Criteria

  • 1\.Patients willing to give informed consent.
  • 2\.Both male and female patients aged more than 18yrs
  • 3\.Patients with clinically diagnosed melasma.
  • 4\.Patients with melasma who have not applied any topical creams since two weeks/ who have not taken oral steroids since the last one month/ done any procedures like lasers/ chemical peels.

Exclusion Criteria

  • 1\. Pregnant and lactating women
  • 2\. Patients on oral contraceptives, phenytoin
  • 3\. Patients on renal dysfunction
  • 4\. Patients allergic to the medications under trial
  • 5\. Patients with acne vulgaris/ rosacea
  • 6\.Patients with facial hair (beard)

Outcomes

Primary Outcomes

Not specified

Similar Trials